NCT02243306 Study to Assess the Pharmacokinetics of GSK1278863 in Subjects With End Stage Renal Disease Undergoing Peritoneal Dialysis Status COMPLETED Phase PHASE1
NCT02242643 Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age Status COMPLETED Phase PHASE3
NCT02236611 A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE4
NCT02233803 A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma Status COMPLETED Phase PHASE4
NCT02231190 GSK1278863 Effects on Eccentric Exercise-Induced Muscle Damage Status COMPLETED Phase PHASE1
NCT02229240 Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus Status WITHDRAWN Phase PHASE3
NCT02229227 Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT02227238 Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line Treatment Status COMPLETED Phase PHASE3
NCT02226562 Clinical Study Investigating the Efficacy of a Mouthwash in Providing Long Term Relief From Dentinal Hypersensitivity Status COMPLETED Phase PHASE2
NCT02224456 Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis Status COMPLETED Phase PHASE4
NCT02223637 Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry Status COMPLETED Phase N/A
NCT02221037 Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery Status TERMINATED Phase PHASE2
NCT02218762 A Study in Patients With Moderate Asthma to Compare Pharmacokinetics and Pharmacodynamic Effects of Fluticasone Propionate and Salmeterol Delivered Via the ROTAHALER® Inhaler Relative to the DISKUS® Inhaler Status WITHDRAWN Phase PHASE1
NCT02218723 Pharmacokinetic Profile of Four Formulations of Fluticasone Furoate (FF) Using Unit Dose Dry Powder Inhaler (UD-DPI) Compared With FF ELLIPTA® Presentation Status COMPLETED Phase PHASE1
NCT02218697 Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older Status COMPLETED Phase PHASE3
NCT02216123 Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria Status COMPLETED Phase PHASE3
NCT02215096 Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE1